Cellebrite DI Ltd.

CLBTW | NASDAQ | 0 Sledující

$5.25

-11.64%

-$0.69

Sledovat

Overview Metrics Financials

Breakdown	12/31/2024 USD	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	401,203 +23.41%	325,110 +20.12%	270,651 +9.91%	246,246 -
Cost of revenue	62,593 +17.59%	53,231 +4.90%	50,746 +19.24%	42,557 -
Gross profit	338,610 +24.54%	271,879 +23.63%	219,905 +7.96%	203,689 -
Operating expense	281,704 +18.04%	238,642 +9.04%	218,861 +15.27%	189,867 -
Operating income	56,906 +71.21%	33,237 +3,083.62%	1,044 -92.45%	13,822 -
Pretax Income	-275,984 -265.24%	-75,563 -162.57%	120,760 +46.72%	82,305 -
Tax Provision	7,023 +26.84%	5,537 +12,404.44%	-45 -100.41%	10,909 -
Net income	-283,007 -248.96%	-81,100 -167.13%	120,805 +69.20%	71,396 -
EPS	-1.35 -213.95%	-0.43 -167.19%	0.64 +28.00%	0.5 -
Diluted EPS	-1.35 -213.95%	-0.43 -172.88%	0.59 +34.09%	0.44 -
Average Shares	209,472 +10.16%	190,155 +4.08%	182,693 +26.87%	144,002 -
Diluted Average Shares	209,472 +10.16%	190,155 -2.68%	195,394 +20.96%	161,539 -
EBIT	56,906 +176.07%	-74,810 -7,265.71%	1,044 -92.45%	13,822 -
EBITDA	67,513 +204.19%	-64,799 -732.93%	10,238 -88.61%	89,876 -

Soubory cookie používáme ke zlepšení prohlížení na webu.